Skip to main content
SpringerLink
Log in

Effect of berberine on expressions of uncoupling protein-2 mRNA and protein in hepatic tissue of non-alcoholic fatty liver disease in rats

  • Original Article
  • Published:
Chinese Journal of Integrative Medicine Aims and scope Submit manuscript

Abstract

Objective

To observe the effect of berberine on uncoupling protein-2 (UCP2) mRNA and protein expressions in the hepatic tissue of non-alcoholic fatty liver disease (NAFLD) in rats, and to explore the molecular mechanism.

Methods

To establish the NAFLD rat model; the rats were fed by high fat forage and were randomly divided into four groups: normal group, model group, berberine high-dose group (324 mg/kg), and berberine low-dose group (162 mg/kg). After treatment for 12 weeks, the expression of UCP2 mRNA in the liver tissue was analyzed by semiquantitative reverse transcription polymerase chain reaction (RT-RTPCR). The expression level of UCP2 protein in the liver tissue was examined by immunohistochemistry. Total PCR). cholesterol (TC), triglyceride (TG), high-density lipoprotein cholesterol (HDL-C), and low-density lipoprotein cholesterol (LDL-C) contents in blood serum, and TG and TC contents in the liver were detected by an automatic biochemical analyzer. The other is to observe the axungia degree of the liver.

Results

The expression of UCP2 mRNA and positive cell numbers in the liver tissue were dramatically increased in the model group (P<0.01). Lipid in the serum and hepatic tissues increased significantly, and the liver was fatty. But in the treatment groups, the expression levels of mRNA and UCP2 proteins were significantly down-regulated (P<0.01). Liver steatosis was improved.

Conclusions

Berberine can down-regulate the expression levels of UCP2 mRNA and UCP2 proteins of hepatic tissue in NAFLD rats. It can promote the recovery of hepatocyte steatosis and improve lipid metabolism disorder in NAFLD rats. Berberine shows a potential therapeutic effect on NAFLD.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Clark JM, Brancati FL, Diehl AM. Non-alcoholic fatty liver disease. Gastroenterology 2002;122:1649–1657.

    Article  PubMed  Google Scholar 

  2. Day CP. Non-alcoholic steatohepatitis (NASH): where are we now and where are we going? Gut 2002;50: 585–588.

    Article  PubMed  CAS  Google Scholar 

  3. Farrell GC, Chitturi S, Lau GKK, Sollano JD. Guidelines for the assessment and management of non-alcoholic fatty liver disease in the Asia-Pacific region: executive summary. J Gastroen Hepatol 2007;22:775–777.

    Article  Google Scholar 

  4. Fleury C, Neverova M, Collins S, Raimbault S, Champigny O, LeviMeyrueis C, et al. Uncoupling protein-2: A novel gene linked to obesity and hyperinsulinemia. Nat Genet 1997;15:269–272.

    Article  PubMed  CAS  Google Scholar 

  5. Larrouy D, Laharrague P, Carrera G, Viguerie-Bascands N, Levi-Meyrueis C, Fleury C, et al. Kupffer cells are a dominant site of uncoupling protein 2 expression in rat liver. Biochem Biophys Res Commun 1997;235:760–764.

    Article  PubMed  CAS  Google Scholar 

  6. Matsuda J, Hosoda K, Itoh H, Son C, Doi K, Tanaka T, et al. Cloning of rat uncoupling protein-3 and uncoupling protein-2 cDNAs: their gene expression in rats fed high-fat diet. FEBS Lett 1997;418:200–204.

    Article  PubMed  CAS  Google Scholar 

  7. Faggioni R, Shigenaga J, Moser A, Smith B, Grunfeld C. Induction of UCP2 gene expression by infection. Biochem Biophys Res Commun 1998;244:75–78.

    Article  PubMed  CAS  Google Scholar 

  8. Cortez-Pinto H, Lin HZ, Yang SQ, Odwin Da Costa S, Diehl AM. Lipids up-regulate uncoupling protein-2 expression in rat hepatocytes. Gastroenterology 1999;116:1184–1193.

    Article  PubMed  CAS  Google Scholar 

  9. Baffy G. Uncoupling protein-2 and non-alcoholic fatty liver disease. Front Biosci 2005;10:2082–2096.

    Article  PubMed  CAS  Google Scholar 

  10. Lee YS, Kim WS, Kim KH, Yoon MJ, Cho HJ, Shen Y, et al. Berberine, a natural plant product, activates AMP-activated protein kinase with beneficial metabolic effects in diabetic and insulin-resistant states. Diabetes 2006;55:2256–2264.

    Article  PubMed  CAS  Google Scholar 

  11. Yin J, Hu R, Chen M, Tang JF, Li FY, Yang Y, et al. Effects of berberine on glucose metabolism in vitro. Metabolism 2002;51:1439–1443.

    Article  PubMed  CAS  Google Scholar 

  12. Leng SH, Lu FE, Xu LJ. Therapeutic effects of berberine in impaired glucose tolerance rats and its influence on insulin secretion. Acta Pharmacol Sin 2004;25:496–502.

    PubMed  CAS  Google Scholar 

  13. Ko BS, Choi SB, Park SK, Jang JS, Kim YE, Park S. Insulin sensitizing and insulinotropic action of berberine from Cortidis rhizoma. Biol Pharm Bull 2005;28:1431–1437.

    Article  PubMed  CAS  Google Scholar 

  14. Brusq JM, Ancellin N, Grondin P, Guillard R, Martin S, Saintillan Y, et al. Inhibition of lipid synthesis through activation of AMP kinase: an additional mechanism for the hypolipidemic effects of berberine. J Lipid Res 2006;47:1281–1288.

    Article  PubMed  CAS  Google Scholar 

  15. Wei J, Jiang JD, Wu JD, Wang SK, Wang ZZ, Pan HN, et al. Research on the effective improvement of hyperlipidemia by berberine. Chin J Diabetes (Chin) 2005;13:49–51.

    Google Scholar 

  16. Huang C, Zhang Y, Gong Z, Sheng XY, Li ZM, Zhang W, et al. Berberine inhibits 3T3-L1 adi-pocyte differentiation through the PPARγ pathway. Biochem Biophys Res Commun 2006;348:571–578.

    Article  PubMed  CAS  Google Scholar 

  17. Shi XY. Experimental zoology of modern medicine. 1st ed. Beijing: People’s Military Medical Press; 2000:334.

    Google Scholar 

  18. Gimeno RE, Dembski M, Weng X, Deng N, Shyjan AW, Gimeno CJ, et al. Cloning and characterization of an uncoupling protein homolog: a potential molecular mediator of human thermogenesis. Diabetes 1997;46:900–906.

    Article  PubMed  CAS  Google Scholar 

  19. Chavin KD, Yang SQ, Lin HZ, Chatham J, Chacko VP, Hoek JB, et al. Obesity induces expression of uncoupling protein-2 in hepatocytes and promotes liver ATP depletion. J Biol Chem 1999;274:5692–5700.

    Article  PubMed  CAS  Google Scholar 

  20. Rashid A, Wu TC, Huang CC, Chen CH, Lin HZ, Yang SQ, et al. Mitochondrial proteins that regulate apoptosis and necrosis are induced in mouse fatty liver. Hepatology 1999;29:1131–1138.

    Article  PubMed  CAS  Google Scholar 

  21. Baffy G, Zhang CY, Glickman JN, Lowell BB. Obesityrelated fatty liver is unchanged in mice deficient for mitochondrial uncoupling protein 2. Hepatology 2002;35:753–761.

    Article  PubMed  CAS  Google Scholar 

  22. Starkel P, Sempoux C, Leclercq I, Herin M, Deby C, Desager JP, et al. Oxidative stress, KLF6 and transforming growth factor-beta up-regulation differentiate non-alcoholic steatohepatitis progressing to fibrosis from uncomplicated steatosis in rats. J Hepatol 2003;39:538–546.

    Article  PubMed  Google Scholar 

  23. Jezek P. Possible physiological roles of mitochondrial uncoupling proteins-UCPn. Int J Biochem Cell Biol 2002;34:1190–1206.

    Article  PubMed  CAS  Google Scholar 

  24. Yang SQ, Zhu H, Li Y, Lin H, Gabrielson K, Trush MA, et al. Mitochondrial adaptations to obesity-related oxidant stress. Arch Biochem Biophys 2000;15:259–268.

    Article  Google Scholar 

  25. Cortez-Pinto H, Yang SQ, Lin HZ, Costa S, Hwang CS, Lane MD, et al. Bacterial lipopolysaccharide induces uncoupling protein-2 expression in hepatocytes by a tumor necrosis factor-alpha-dependent mechanism. Biochem Biophys Res Commun 1998;251:313–319.

    Article  PubMed  CAS  Google Scholar 

  26. Cortez-Pinto H, Chatham J, Chacko VP, Arnold C, Rashid A, Diehl AM. Alterations in liver ATP homeostasis in human nonalcoholic steatohepatitis: a pilot study. JAMA 1999;282:1659–1664.

    Article  PubMed  CAS  Google Scholar 

  27. Vidal-Puig AJ. Uncoupling expectations. Nat Genet 2000;26:387–388.

    Article  PubMed  CAS  Google Scholar 

  28. Evans ZP, Ellett JD, Schmidt MG, Schnellmann RG, Chavin KD. Mitochondrial uncoupling protein-2 mediates steatotic liver injury following ischemia/reperfusion. J Biol Chem 2008;283:8573–8579.

    Article  PubMed  CAS  Google Scholar 

  29. Fulop P, Derdak Z, Sheets A, Sabo E, Berthiaume EP, Resnick MB, et al. Lack of UCP2 reduces Fas-mediated liver injury in ob/ob mice and reveals importance of cellspecific UCP2 expression. Hepatology 2006;44:592–601.

    Article  PubMed  CAS  Google Scholar 

  30. Lin HZ, Yang SQ, Chuckaree C, Kuhajda F, Ronnet G, Diehl AM. Metformin reverses fatty liver disease in obese, leptin-deficient mice. Nat Med 2000;6:998–1003.

    Article  PubMed  CAS  Google Scholar 

  31. Li ZP, Yang SQ, Lin HZ, Huang J, Watkins PA, Moser AB, et al. Probiotics and antibodies to TNF inhibit inflammatory activity and improve nonalcoholic fatty liver disease. Hepatology 2003;37:343–350.

    Article  PubMed  CAS  Google Scholar 

  32. Day CP, James OFW. Steatohepatitis: a tale of two “hits”? Gastroenterology 1998;114:842–845.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Traditional Chinese Medicine, Medical College, Jinan University, Guangzhou, 510632, China

    Qin-he Yang  (杨钦河), Si-ping Hu  (胡四平), Yu-pei Zhang  (张玉佩), Na Li  (李 娜), Gui-yuan Ji  (纪桂元), Na-li Qiao  (乔娜丽), Xiu-feng Lin  (林秀峰), Tong-yan Chen  (陈同炎) & Hai-tao Liu  (刘海涛)

  2. Guangdong Province Integrative Medicine Hospital, Foshan, Guangdong Province, 528222, China

    Wei-ning Xie  (谢维宁)

Authors
  1. Qin-he Yang  (杨钦河)
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Si-ping Hu  (胡四平)
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yu-pei Zhang  (张玉佩)
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Wei-ning Xie  (谢维宁)
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Na Li  (李 娜)
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Gui-yuan Ji  (纪桂元)
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Na-li Qiao  (乔娜丽)
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Xiu-feng Lin  (林秀峰)
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Tong-yan Chen  (陈同炎)
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Hai-tao Liu  (刘海涛)
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Qin-he Yang  (杨钦河).

Rights and permissions

Reprints and permissions

About this article

Cite this article

Yang, Qh., Hu, Sp., Zhang, Yp. et al. Effect of berberine on expressions of uncoupling protein-2 mRNA and protein in hepatic tissue of non-alcoholic fatty liver disease in rats. Chin. J. Integr. Med. 17, 205–211 (2011). https://doi.org/10.1007/s11655-011-0668-4

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11655-011-0668-4

Keywords

Search

Navigation